Full Text View
Tabular View
No Study Results Posted
Related Studies
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
This study is currently recruiting participants.
Study NCT00363584   Information provided by National Cancer Institute (NCI)
First Received: August 10, 2006   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Liver Cancer
Additional conditions recognized in this trial
Bile Duct Neoplasms
Biliary Tract Neoplasms
Gallbladder Neoplasms
Liver Neoplasms
More general conditions related to this trial
Bile Duct Diseases
Biliary Tract Diseases
Digestive System Diseases
Digestive System Neoplasms
Gallbladder Diseases
Liver Diseases
Neoplasms
Neoplasms by Site
Interventions listed in this trial
capecitabine
adjuvant therapy
observation
Additional drug interventions recognized in this trial
Adjuvants, Immunologic
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Southampton General Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services